Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
Regulus Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 49.46M | 38.53M | 26.37M | 17.18M | 29.65M | 23.83M | 25.83M | 37.26M | 30.31M | 24.23M | 20.01M | 35.12M | 53.9M | 60.38M | 35.85M | 41.44M | 31.6M |
Short-Term Investments | 15.91M | 37.25M | 60.94M | 77.34M | 67.97M | n/a | 4.95M | n/a | n/a | 14.93M | 25.31M | 12.41M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 1.47M | 10.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | 3.2M | 3.08M | 3.01M | n/a | n/a | n/a | n/a | n/a | n/a | 148K | 291K | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | -3.01M | n/a | n/a | 3K | 4K | n/a | n/a | n/a | 8K | n/a | n/a | 194K | 72K |
Inventory | n/a | n/a | n/a | 3.18M | 3.01M | 3.01K | 3.01K | 3.07M | 3.07M | 3.01K | 3.01K | 3.01K | 3.07M | 3.01M | 3.01M | 3.33M | 3.38M |
Other Current Assets | 2.85M | 3.08M | 4.38M | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K | 62K |
Total Current Assets | 71.69M | 82.34M | 91.69M | 97.16M | 98.44M | 25.17M | 35.08M | 41.36M | 34.56M | 44.08M | 49.37M | 51.4M | 57.93M | 65.23M | 39.99M | 46.31M | 36.54M |
Property-Plant & Equipment | 3.11M | 1.81M | 2.05M | 2.26M | 2.42M | 2.54M | 2.63M | 2.25M | 2.4M | 2.58M | 2.69M | 2.83M | 2.83M | 2.85M | 2.97M | 3.1M | 3.19M |
Goodwill & Intangibles | 23K | 25K | 25K | 27K | 30K | 33K | 36K | 39K | 58K | 62K | 67K | 70K | 74K | 83K | 89K | 105K | 116K |
Total Long-Term Assets | 3.13M | 1.84M | 2.08M | 6.96M | 15.7M | 5.58M | 2.67M | 2.28M | 2.45M | 2.64M | 2.75M | 2.9M | 3.05M | 3.22M | 3.06M | 3.2M | 3.3M |
Total Assets | 74.83M | 84.18M | 93.76M | 104.12M | 114.14M | 30.75M | 37.75M | 43.65M | 37.02M | 46.72M | 52.13M | 54.3M | 60.98M | 68.45M | 43.04M | 49.52M | 39.84M |
Account Payables | 200K | 947K | 792K | 601K | 406K | 204K | 599K | 362K | 581K | 175K | 796K | 595K | 625K | 285K | 586K | 1.39M | 810K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 3.55M | 2.91M | n/a | n/a | n/a | n/a | n/a | -589K | 4.55M | 2.4M | 2.15M |
Short-Term Debt | n/a | n/a | n/a | n/a | 540K | 1.33M | 2.13M | 2.92M | 3.72M | 4.51M | 4.48M | 1.65M | 826K | n/a | 4.67M | 4.66M | 4.66M |
Other Current Liabilities | 2.24M | 5.04M | 5.69M | 801K | 2.25M | 2.38M | 1.97M | 2.04M | 2.29M | 2.55M | 1.85M | 619K | 957K | 1.29M | 4.78M | 2.75M | 3.6M |
Total Current Liabilities | 4.4M | 7.5M | 6.48M | 5.26M | 5.68M | 8.51M | 8.25M | 8.23M | 8.82M | 11.66M | 10.52M | 5.83M | 4.7M | 5.23M | 11.46M | 9.97M | 9.86M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.79M | 3.59M | 4.67M | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.21M | 1.19M | 1.18M | n/a | n/a | n/a |
Total Long-Term Liabilities | 1.4M | 274K | 476K | 675K | 868K | 1.05M | 1.24M | 1.42M | 1.6M | 1.77M | 1.94M | 6.1M | 7.04M | 8.27M | 2.57M | 2.72M | 2.87M |
Total Liabilities | 5.8M | 7.77M | 6.96M | 5.94M | 6.55M | 9.56M | 9.49M | 9.65M | 10.42M | 13.43M | 12.46M | 11.93M | 11.74M | 13.5M | 14.03M | 12.69M | 12.73M |
Total Debt | 1.4M | 274K | 476K | 1.42M | 2.14M | 3.1M | 3.37M | 4.34M | 5.31M | 6.28M | 6.41M | 6.55M | 6.68M | 7.09M | 7.24M | 7.38M | 7.52M |
Common Stock | 66K | 66K | 66K | 65K | 65K | 20K | 20K | 19K | 17K | 17K | 17K | 15K | 146K | 146K | 87K | 87K | 75K |
Retained Earnings | -569.21M | -559.57M | -546.78M | -532.72M | -521.68M | -513.21M | -505.15M | -497.33M | -490.31M | -483.18M | -476.38M | -468.83M | -461.57M | -454.85M | -447.72M | -439.09M | -433.06M |
Comprehensive Income | 10K | 50K | n/a | -87K | -45K | -20K | -1K | -1K | -0.00 | -12K | -31K | -36K | n/a | n/a | 0.00 | -0.00 | n/a |
Shareholders Equity | 69.03M | 76.41M | 86.81M | 98.18M | 107.59M | 21.19M | 28.26M | 34M | 26.59M | 33.29M | 39.67M | 42.37M | 49.24M | 54.96M | 29.01M | 36.83M | 27.11M |
Total Investments | 15.91M | 37.25M | 60.94M | 78.81M | 78.14M | n/a | 4.95M | n/a | n/a | 14.93M | 25.31M | 12.41M | n/a | n/a | n/a | n/a | n/a |